Atlas Trials

A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

Clinical trial NCT00231634 · TERMINATED

Trial details

NCT number
NCT00231634
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Start date
2001-05-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.